EPISODE · Jun 18, 2026 · 22 MIN
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
from JAMA Medical News
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
Embed this episode
NOW PLAYING
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
0:00
22:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Medical News?
This episode is 22 minutes long.
When was this JAMA Medical News episode published?
This episode was published on June 18, 2026.
Can I download this JAMA Medical News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!